↑ トップへ ← 戻る

 Drug(薬物リスト) ALL | DrugBank 

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

17 / 1,666 drugs found* Show info (disease name, etc.) on mouse-over.
 No.   DrugBank   薬物名(臨床試験情報から抽出)   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   Bevacizumab  4件: Bevacizumab; Bevacizumab (genitical recombination); Bevacizumab (avastin) and imatinib mesylate (gleevec); Submucosal bevacizumab;   D06409   1件: VEGFA   3件: Pathways in cancer, Renal cell carcinoma, VEGF signaling pathway   9件:
13,
34,
85,
86,
87,
89,
227,
280,
331
 2   Celecoxib  7件: Celecoxib; Fixed dose combination ciprofloxacin/celecoxib; Celecoxib (celebrex); Celecoxib 200mg capsule; Celecoxib 200 milligrams; Celecoxib 400 milligrams; Celecoxib, celebrex®;   D00567   1件: PTGS2   1件: Arachidonic acid metabolism   9件:
2,
3,
34,
46,
70,
89,
96,
161,
271
 3   Cetuximab  1件: Cetuximab;   D03455   1件: EGFR   3件: ErbB signaling pathway, MAPK signaling pathway, Pathways in cancer   5件:
34,
51,
86,
89,
331
 4   Doxycycline  7件: Doxycycline; Interferon beta 1a, oral doxycycline; Doxycycline hyclate; Antimicrobial therapy: co-trimoxazole or doxycycline; Doxycycline 100 mg capsules; Treatment with systemic therapy (doxycycline); Doxycycline hyclate ph.eur;   D00307
 D02129
 D03903
 D03904
 D07876 
 -   -   15件:
13,
23,
28,
46,
84,
85,
89,
96,
97,
158,
162,
167,
227,
280,
299
 5   Everolimus  6件: Everolimus; Everolimus (rad001); Everolimus (rad001) , afinitor®; Rad001, everolimus; Rad001: everolimus; Afinitor (everolimus);   D02714   1件: MTOR   4件: Breast cancer, ErbB signaling pathway, Pathways in cancer, mTOR signaling pathway   9件:
34,
67,
89,
96,
137,
157,
158,
228,
277
 6   Hydroxychloroquine  16件: Hydroxychloroquine; Hydroxychloroquine sulfate; Leflunomide-sulfasalazine-hydroxychloroquine; Methotrexate + salazopyrine + hydroxychloroquine administration; Methotrexate-sulfasalazine-hydroxychloroquine; Sulphasalazine + hydroxychloroquine or prednisolone; Hydroxychloroquine (z0188); Hydroxychloroquine high; Hydroxychloroquine or chloroquine; Hydroxychloroquine reduced; Versus hydroxychloroquine; Hydroxychloroquine + prednisone; Sirolimus and hydroxychloroquine; Hydroxychloroquine higher dose; Hydroxychloroquine lower dose; Hydroxychloroquine sulphate;   D08050   -   -   18件:
13,
41,
46,
48,
49,
53,
56,
66,
84,
89,
90,
96,
222,
234,
254,
271,
298,
299
 7   Imatinib  6件: Imatinib; Imatinib mesilate; Imatinib mesylate; Imatinib mesylate (gleevec); Bevacizumab (avastin) and imatinib mesylate (gleevec); Imatinib mesylate 400mg capsule;   D01441
 D08066 
 3件: ABL1, KIT, PDGFRA   3件: Chronic myeloid leukemia, MAPK signaling pathway, Pathways in cancer   11件:
13,
28,
34,
35,
46,
51,
85,
86,
87,
89,
162
 8   Letrozole  1件: Letrozole;   D00964   1件: CYP19A1   1件: Steroid hormone biosynthesis   2件:
81,
89
 9   Nintedanib  5件: Nintedanib; L01xe31 - nintedanib; Pirfenidone and nintedanib; Pirfenidone or nintedanib; Sub-study: nintedanib;   D10481   8件: FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB   3件: MAPK signaling pathway, Pathways in cancer, VEGF signaling pathway   4件:
51,
85,
89,
228
 10   Octreotide  5件: Octreotide; Octreotide lar; Octreotide-lar; Gallium-68-dota-n-octreotide; Octreotide lar / sandostatin lar (lar=long acting release);   D00442
 D06495 
 1件: SSTR2   3件: Gastric acid secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway   8件:
67,
75,
84,
85,
89,
96,
193,
227
 11   Resveratrol  1件: Resveratrol;   -   -   -   3件:
8,
89,
113
 12   Salbutamol  5件: Salbutamol; Salbutamol 4mg tablet; R-salbutamol; R-salbutamol sulphate; Nebulized combination ipratropium bromide with salbutamol;   D02147   1件: ADRB2   3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, cAMP signaling pathway   13件:
3,
11,
12,
13,
49,
85,
86,
89,
113,
228,
231,
256,
299
 13   Saracatinib  1件: Saracatinib;   D09664   2件: ABL1, SRC   3件: Chemokine signaling pathway, ErbB signaling pathway, VEGF signaling pathway   2件:
6,
89
 14   Simvastatin  16件: Simvastatin; Simvastatine; Encapsulated simvastatin tablets; Simvastatin 40 mg film-coated tablets; Simvastatin alternova; Simvastatina; Simvastatina sandoz 40 mg comprimidos recubiertos con película efg; Simvastatine sandoz 40 mg filmomhulde tabletten; Simvastatine sandoz 40mg deelbare filmomhulde tabletten; Simvastatin 20mg/5ml oral suspension; Ezetimibe+simvastatin drug combination; Simvastatin 40mg; Simvastatin-ratiopharm; Simvastatin-ratiopharm®; Simvastatin treatment for 28 days; Simvastatin susp.;   D00434   1件: HMGCR   1件: Terpenoid backbone biosynthesis   19件:
6,
13,
15,
34,
46,
49,
51,
66,
79,
86,
89,
94,
158,
162,
195,
265,
298,
299,
310
 15   Sirolimus  16件: Sirolimus; Temsirolimus; Temsirolimus tablets; Sirolimus 2 mg; Skincerity plus sirolimus/rapamycin; Skinercity plus sirolimus/rapamycin; Sirolimus (formerly known as rapamycin); Sirolimus 2%; Sirolimus, 2%; Rapamycin, sirolimus; Sirolimus and hydroxychloroquine; Sirolimus 0.2%; Sirolimus 0.4%; Sirolimus 0,1% crème; Sirolimus oral liquid product 1mg/ml; Topical 0.1% sirolimus;   D00753   1件: MTOR   2件: Pathways in cancer, mTOR signaling pathway   36件:
2,
13,
15,
17,
34,
35,
36,
46,
49,
51,
60,
61,
62,
63,
65,
66,
67,
85,
86,
89,
96,
98,
137,
157,
158,
192,
222,
256,
277,
278,
279,
280,
281,
283,
285,
331
 16   Temsirolimus  2件: Temsirolimus; Temsirolimus tablets;   D06068   1件: MTOR   3件: ErbB signaling pathway, Pathways in cancer, mTOR signaling pathway   4件:
13,
34,
89,
331
 17   Valproic Acid  3件: Valproic acid; Valproic acid (vpa); Valproic acid and levocarnitine;   D00399   6件: ABAT, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2   2件: Calcium signaling pathway, GABAergic synapse   14件:
2,
3,
5,
8,
26,
34,
65,
89,
90,
102,
222,
233,
256,
331